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Abstract

Significance: A key role of the tumor microenvironment (TME) in cancer progression, treatment resistance, and
as a target for therapeutic intervention is increasingly appreciated. Among important physiological components of
the TME are tissue hypoxia, acidosis, high reducing capacity, elevated concentrations of intracellular glutathione
(GSH), and interstitial inorganic phosphate (Pi). Noninvasive in vivo pO2, pH, GSH, Pi, and redox assessment
provide unique insights into biological processes in the TME, and may serve as a tool for preclinical screening of
anticancer drugs and optimizing TME-targeted therapeutic strategies.
Recent Advances: A reasonable radiofrequency penetration depth in living tissues and progress in development
of functional paramagnetic probes make low-field electron paramagnetic resonance (EPR)-based spectroscopy
and imaging the most appropriate approaches for noninvasive assessment of the TME parameters.
Critical Issues: Here we overview the current status of EPR approaches used in combination with functional
paramagnetic probes that provide quantitative information on chemical TME and redox ( pO2, pH, redox status,
Pi, and GSH). In particular, an application of a recently developed dual-function pH and redox nitroxide probe
and multifunctional trityl probe provides unsurpassed opportunity for in vivo concurrent measurements of
several TME parameters in preclinical studies. The measurements of several parameters using a single probe
allow for their correlation analyses independent of probe distribution and time of measurements.
Future Directions: The recent progress in clinical EPR instrumentation and development of biocompatible
paramagnetic probes for in vivo multifunctional TME profiling eventually will make possible translation of
these EPR techniques into clinical settings to improve prediction power of early diagnostics for the malignant
transition and for future rational design of TME-targeted anticancer therapeutics. Antioxid. Redox Signal. 28,
1365–1377.
Keywords: tumor microenvironment, electron paramagnetic resonance, tumor hypoxia, tumor acidosis, tumor
redox, paramagnetic probes
Introduction

T

umor microenvironment (TME) is a key support system of cancer that includes physical components such as
extracellular matrix, blood vessels, and various types of cells of
the particular organ, and physiological components. Among
TME parameters of critical importance for physiology in solid
tumors, compromised tissue oxygenation (101, 104), acidification (12, 37), accumulation of reducing equivalents (81),

elevated concentrations of intracellular glutathione (GSH) (33,
105), and interstitial inorganic phosphate (Pi) (9) are well
documented. Tumor tissue hypoxia (101) resulted from the
undeveloped blood vessels is associated with a higher dependence on glycolytic metabolism (106) and corresponding TME
acidosis (12, 37, 44). Metabolic alterations affect the tissue
redox and result in accumulation of reducing equivalents (81),
including a significant increase of GSH, key component of
intracellular redox buffer (33, 105). Interstitial Pi has been
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recently recognized as an emerging signaling molecule
playing a role in promoting cell transformation and tumorigenesis (14–16, 51, 52, 97), and a new TME marker of tumor
progression and aggressiveness (9).
Individual cancer cells generated by causal genetic insults
behave differently depending on their specific tissue microenvironment. Numerous therapeutic strategies elaborated in
cellular systems in vitro in the absence of TME factors are not
reproduced in further studies in animals and humans. There is
approaching scientific consensus that in vivo TME profiling
opens opportunities for preclinical screening of anticancer
drugs and predicting therapeutic effectiveness, as well as
developing new diagnostics and noninvasive guided therapeutic strategies based on TME manipulation.
A reasonable radiofrequency penetration depth in tissues
makes magnetic resonance imaging (MRI) and low-field
electron paramagnetic resonance (EPR)-based techniques
the most appropriate approaches for noninvasive assessment
of the chemical TME parameters such as pO2, extracellular
pH (pHe), phosphate (Pi), GSH, and redox. MRI relies largely
on imaging of water protons and is widely used in clinical
settings providing anatomical resolution while lacking
functional sensitivity. Potentially attractive 31P NMR measurements of extracellular [Pi] and pH based on a signal from
endogenous phosphate are normally masked by several-fold
higher intracellular Pi concentrations (36, 37). In contrary
to the NMR applications, EPR measurements rely on spectroscopy and imaging of specially designed paramagnetic
probes providing functional sensitivity. Note that exogenous
EPR probes have advantages over exogenous NMR probes
due to a much higher intrinsic sensitivity of EPR and absence
of endogenous background EPR signals.
In vivo EPR applications rely on use of both particulate and
soluble paramagnetic probes (see Fig. 1 for the exemplified
structures). Advantages of particulate probes used for EPR
oximetry are high functional sensitivity, stability in living
tissue, and minimal toxicity (11, 34, 76, 90). The particulate
probe may remain in the place of implantation for long periods of time, enabling repeated measurements of tissue pO2
for up to weeks and months after implantation. On the contrary, soluble nitroxide (NR) and triarylmethyl (TAM) probes
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may possess functional sensitivity to various parameters of
TME such as pO2, pH, Pi, redox, and GSH (9, 10, 20, 93) and
allow for spatially resolved measurements using EPR-based
imaging techniques (13, 29, 66, 70, 94). The developments of
a dual-function pH and redox nitroxide probes, NR1 and NR2
(10, 94), GSH probe (59, 93), and multifunctional pH, pO2,
and Pi trityl probe (20), shown in Figure 2, provide unsurpassed opportunities for in vivo concurrent measurements of
several TME parameters and their correlation analyses independent of probe distribution and time of measurement (9).
Here we overview the recent advances of in vivo molecular
EPR-based spectroscopy and imaging of TME and redox
using functional paramagnetic probes, and applications of
these approaches in various animal models of cancer.
In vivo EPR oximetry of TME

Significant oxygen deficiency has been reported for many
tumors, which is associated with the tumor-increased resistance toward radiation and chemotherapy (19, 47, 104). The
hypoxic TME promotes processes driving malignant progression, such as angiogenesis, genetic instability, and metastasis (46, 83). Therefore, noninvasive and real-time pO2
measurements using EPR oximetry are of importance in
preclinical research and have the potential for clinical applications (100).
EPR oximetry is predominantly based on the physical
phenomenon of Heisenberg spin exchange between the
molecules of paramagnetic probe and oxygen, which does not
interfere with oxygen metabolism, therefore providing basis
for noninvasive EPR oxygen measurements in biological
systems. Spin-exchange of the radical probe with comparatively long relaxation time and oxygen diradical molecule
with short relaxation time results in shortening both the
longitudinal (T1) and transverse (T2) relaxation times of the
probe in inverse proportionality to the rate of encounter of
probe and oxygen molecules, which in turn is proportional to
oxygen concentration and oxygen partial pressure (27, 49).
NRs were the first paramagnetic probes used for EPR oximetry (2, 3, 41, 71). Backer et al. (3) pioneered applications
of continuous waves (CW) EPR T2 oximetry method based

FIG. 1. Chemical structures of the EPR oximetric probes discussed in the text. Particulate LiNc-BuO, soluble
nitroxide probes, mHCTPO, PDT, 15N-DCP, and 14N-DCP, and soluble trityl radicals, OX063 and OX071. EPR, electron
paramagnetic resonance.

EPR PROFILING OF TUMOR MICROENVIRONMENT

1367

FIG. 2. Chemical structures of
the soluble paramagnetic probes
for multifunctional TME profiling discussed in the text. pH and
redox probes, NR1 and its deuterated analog, NR2; disulfide biradical probe for GSH detection,
RSSR; and multifunctional pH,
pO2, and Pi probe of extracellular
microenvironment, HOPE. GSH,
glutathione; TME, tumor microenvironment.

on oxygen-induced line broadening of the NR probe (for
Lorentzian lineshape EPR linewidth, DH ¼ 1=(ce T2 ), where
ge = 1.76 · 107 s-1 Gauss-1 is electron gyromagnetic ratio). In
this approach, accuracy of pO2 measurements is largely defined by the probe linewidth and oxygen-induced line
broadening effect. For aqueous NR solutions, the typical value
of the line-broadening effect is about 500 mG/mM of oxygen
(&0.6 mG/mmHg of pO2), which results in comparatively low
accuracy of pO2 measurements using the NR probes with
a typical linewidth of about 1 G (ca. –20 mmHg of pO2). The
use of perdeuterated NRs (such as PDT, Fig. 1) significantly
increases accuracy of pO2 assessment (68) but still the measurements are complicated by overlap of the effects of oxygeninduced line broadening and concentration-induced line
broadening (ca. 100–200 mG/mM). To discriminate between
the latter two factors, Halpern et al. (41) used partially deuterated mHCTPO NR (Fig. 1) with only one observable superhyperfine splitting originated from hydrogen atom at carbon
C4 of heterocycle. Both oxygen and radical concentrations
affect the linewidth, while only an increase in probe concentration but not oxygen results in narrowing of hydrogen
hyperfine splitting. Authors demonstrated method utility for
noninvasive assessment of TME oxygenation, for example,
observing a clear pO2 difference measured in a mouse model of
FSa tumor for animals breathing oxygen (42 – 8 mmHg) or air
(7 – 8 mmHg). Recently, an alternative approach to discriminate between oxygen- and concentration-induced line broadenings of the NR probes has been proposed by Kubota et al.
(67) based on the use of two isotopic forms of perdeuterated
dicarboxy pyrrolidine NR (Fig. 1). 15N-DCP and 14N-DCP
NRs show the different concentration-induced line broadenings, in part, due to the different nuclear statistical factors equal
to 1/2 and 2/3 correspondingly, the consequence of absence of
line broadening for the spin-exchange between the NRs with
the same projections of nitrogen nuclear spin (86).
The NRs were the first probes explored for mapping oxygen environment using EPR imaging (EPRI) (68) and dynamic nuclear polarization imaging (40) (also termed proton/
electron double-resonance imaging, PEDRI, or Overhauser enhanced MRI, OMRI). However, comparatively broad NR
spectral lines complicate their oximetric imaging application,
particularly for pulsed EPRI (50). Further progress in EPR
oximetry was enabled by the development of the trityl radicals or TAMs by Nycomed Innovation (1). TAM probes show
a single narrow EPR line with the width of about 100 mG or
lower [160 mG for OX063 and 80 mG for OX071 (27), see
Fig. 1 for the structures]. The oxygen-induced line broad-

ening of the TAMs in aqueous solutions is about 500 mG/mM
of oxygen (1, 6), similar to that for the NRs, while the concentration broadening is about 10 mG/mM (1, 82), which is
one order of magnitude less than that for the NRs. These
factors make TAMs preferable EPR oximetric soluble probes
with oxygen sensitivity approaching 1 mmHg of pO2.
TAM probes were first proposed as advanced oximetric
probes for PEDRI (66) due to their long relaxation times
allowing for easy saturation of EPR transitions. The presence
of oxygen shortens the relaxation times and consequently
results in the decreased transfer of polarization from electron
to nuclear spins during the EPR irradiation. In vivo oximetry
is one of the most straightforward and useful applications of
PEDRI (1, 66) overviewed by Kishimoto et al. in a separate
review of this Forum (61).
Elas et al. (23) demonstrated a utility of CW EPRI using
TAM probes for pO2 mapping and identifying hypoxic areas
in TME. Spectral–spatial CW EPRI provided spatial resolution of (1 mm)3 and pO2 accuracy of about 3–4 mmHg with
acquisition time of about 20 min (23). Long relaxation times
of the TAM probes open opportunity to apply pulsed EPR
techniques further advancing pO2 mapping. In addition to
elimination of object motion artifacts, pulsed EPRI decreases
acquisition times. Time-domain pulsed EPR measurements of
free induction decay allow for imaging the decay time, (T2 ), or
linewidth, (DH ¼ 1=(ce T2 ), converted to pO2 map (82). Applications of pulsed EPR oximetry to image TME, including
monitoring kinetics of tumor oxygenation, validation of hypoxic cancer models, coregistration with other imaging modalities, and treatment response to anticancer therapy, are
overviewed in a separate review of this Forum (62). Note that
accuracy of oxygen measurements using T2 -based Fourier
transform EPRI can be affected by concentration-induced line
broadening, for example, at high local probe concentrations
often used in imaging experiments.
Recently, Halpern and colleagues (27, 28, 30) demonstrated that spin-lattice relaxation (T1)-based EPRI oximetry
using TAM probes has significant advantages compared to
(T2)-based analogs. Both longitudinal and transverse relaxation rates, R1 and R2, or the corresponding inverse relaxation times, 1/T1 and 1/T2, of TAMs are linearly proportional
to pO2 with a similar sensitivity. However, T1 is about one
order of magnitude less sensitive to probe concentration selfrelaxation compared with that for T2. This facilitates highprecision measurements and imaging of the oxygen tension
using spin-lattice relaxation EPR in live animal tissues with
1 mmHg pO2 resolution and 1 mm spatial resolution, and

1368

acquisition time of 10 min or less. An exemplified threedimensional oxygen map of fibrosarcoma tumor obtained
with T1-based EPRI is shown in Figure 3 demonstrating high
pO2 heterogeneity of TME and clearly identifying hypoxic
areas (29).
Authors suggested (29) that that EPR images of tumor
regions with low oxygenation can be used as a tool to guide
radiation therapy. The first preliminary data obtained in a
fibrosarcoma mouse model with targeting small hypoxic areas of tumor using conformal radiation therapy demonstrate
the promising enhancement of cancer radiation treatment.
Current development of the EPR imaging oximetry using
TAM probes such asOX071 (29) opens the path to human
applications but their potential clinical translation hinges on
achieving regulatory approval for the use of these imaging
agents in human subjects, requiring significant investment.
Particulate probes have certain advantages for potential
clinical translation. In addition to already mentioned high
functional sensitivity, stability in living tissue, minimal toxicity, and capacity for repetitive measurements during
months after implantation (11, 34, 76, 90, 99, 100, 107), they
can more readily be approved for use in human subjects. Of
the particulate oximetric probes, India ink has been previously approved for clinical use as an anatomical marker, and
it has been the first probe used for tissue pO2 measurements in
humans by Swartz and his colleagues (99, 107). Alternative
probes such as LiPc derivatives (76, 89, 91) have an advantage
over India ink in oxygen sensitivity. Recently, Kuppusamy and
his colleagues encapsulated LiNc-BuO probe (Fig. 1) in an
oxygen-permeable polymer polydimethylsiloxane (84, 85), a
biocompatible silicone material used in a wide range of medical applications. The authors termed the obtained oxygen
sensor as OxyChip and demonstrated its high oxygen sensitivity and safety in animal models (84, 85). Recently, the Phase
I clinical trial on oxygen measurements in subcutaneous tumors by EPR oximetry using OxyChip has been sponsored by
the Dartmouth-Hitchcock Medical Center and National Cancer
Institute (17).

FIG. 3. Three-dimensional oxygen map of mouse fibrosarcoma tumor bearing leg. Tumor outline, from a
registered MRI image, is shown in red. Reproduced from
Ref. (29) with permission. MRI, magnetic resonance imaging. To see this illustration in color, the reader is referred to
the web version of this article at www.liebertpub.com/ars
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In vivo EPR assessment of reducing capacity
and acidosis of TME

Tumor reliance on glycolysis is known to generate significant alterations in the TME acidity and redox status. Areas of
hypoxia and acidosis are common features of TME in solid
tumors. Cells that exist in such adverse TME conditions can
significantly alter the tumor response to cytotoxic anticancer
therapies. The acidic extracellular pH in tumors has a number
of important consequences, playing a role in tumor initiation,
progression, and therapy (37). pHe has been identified as a
significant prognostic factor both in experimental transplantable tumor models and in spontaneous tumors (79). In its turn,
high reducing capacity of TME is an important determinant in
the response of the tumor to certain chemotherapeutic agents,
radiation, and bioreductive cell cytotoxins (18).
NRs and TAMs containing ionizable group with an equilibrium constant Ka, exist in aqueous solution in protonated,
RH+, and unprotonated, R, forms. EPR measurements of the
ratio of their concentrations allow for calculation of the pH
values based on the Henderson–Hasselbalch equation, [RH+]/
[R] = [H+]/Ka. Among the various NR types, imidazoline
and imidazolidine nitroxides have been used in most EPR
spectroscopy and imaging pH metric applications (53, 56)
due to the significant changes of the EPR spectral parameters on protonation of nitrogen atom N-3 (DaN & 1 G and
Dg & 0.0002) (58). Recently, pH-sensitive trityl radicals
were also synthesized (7, 20). One of the great strengths of
the EPR pH probes is that the method is ratiometric, the pH
measurement being independent of the probe concentration
but dependent on the ratio, [RH+]/[R]. Spectral simulation or
spectral parameters sensitive to [RH+]/[R] ratio can be used
for accurate pH determination. The spectral parameters used
as pH markers include the ratio of peak intensities when RH+

FIG. 4. pH-Dependence of the observed hyperfine
splitting constant, aN, of the NR1 probe. L-band
EPR spectra were acquired at 37C. The solid line is
the fit of experimental data with standard titration curve
aN ¼ (aN (NR1  H þ ) þ aN (NR1) 10pH  pK )=(1 þ 10pH  pK )
yielding pKa = 6.6, aN(NR1-H+) = 14.24 G, and aN(NR1) =
15.27 G. Insert: Exemplified EPR spectrum of 1 mM NR1
solution. The measured hyperfine splitting constant, 14.63
G. Adapted from Ref. (64) with permission from John
Wiley & Sons, Inc.
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FIG. 5. Illustration of the nitroxide/hydroxylamine
redox couple. In living tissue, one-electron reduction of the
nitroxides prevails over hydroxylamine oxidation and the
equilibrium is strongly shifted toward the hydroxylamine (63).

and R signals are resolved, and the observed hyperfine
splitting, aN, measured as a distance between the EPR lines of
the triplet when RH+ and R signals are overlapped. Sensitivity
of the observed aN value to pH depends on the spectrometer
frequency and settings such as modulation amplitude (57).
Figure 4 shows the observed aN dependence of the NR1
radical on pH described by a standard titration curve. Note
that the structure of NR1 probe has been specially designed
for the pH measurements in extracellular TME. First, value of
the pKa of the NR1 radical, 6.6 at 37C (10), allows for in vivo
pH measurements in the range from 5.6 to 7.6 (accuracy, 0.05
pH units), which covers the range of acidic pH in solid tumors. Binding of cell-impermeable GSH tripeptide to the
NR1 restricts its penetration into the cells ensuring EPR
measurements of extracellular pH values (108). The bulky
ethyl groups at carbons C2 and C5 provide steric hindrance
around the radical fragment significantly decreasing the rate
of reduction (60) in a highly reducing microenvironment.
The EPR signal decay due to NR reduction to the corresponding hydroxylamines (Fig. 5) in living tissues is often
considered as a limiting factor in EPR applications of the NR
probes. On the positive side, the rates of the nitroxide decay
allow for EPR evaluation of the tissue reducing capacity in
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various physiological and pathophysiological states (10, 70,
88). In its turn, cyclic hydroxylamines can be oxidized by
biological oxidants into the corresponding EPR-measured
NRs and provide useful information on oxidative stress and
reactive oxygen species (ROS) generation. In contrast to the
EPR spin-trapping approach (4, 43), oxidation of hydroxylamines is not oxidant specific and their use to measure specific ROS requires additional controls. In vitro and in vivo
applications of cyclic hydroxylamine are reviewed in this
Forum by Dikalov et al. (21).
An application of cell-permeable NRs allows for EPR assessment of intracellular redox status (69, 70), while application of cell-impermeable NRs allows for assessment of the
reducing capacity of extracellular matrix. Note that in case of
pH-sensitive NRs, redox-sensitive marker, signal amplitude,
and pH-sensitive marker, aN, are independent spectral parameters, therefore making these NRs dual-function pH and redox
probes. Figure 6 exemplifies the pH and redox measurements
in mouse model of breast cancer (10) using NR1 probe. The
data obtained for the group of female FVB/N MMTV-PyMT
mice in tumors and normal mammary glands support extracellular acidosis and high reducing capacity of TME.
Note that tumor tissue is characterized by high heterogeneity, and therefore, spatially resolved functional measurements of TME are critically important, for example, allowing
identification of the area with compromised redox and pH
homeostasis. Both EPR imaging (13, 54, 70) and PEDRI (65,
94) were explored for redox and pH mapping. In case of
PEDRI, the deuterated analog of the NR1 probe, NR2
(Fig. 2), has been used for pH mapping of TME in mouse
model of breast cancer (61, 94). The narrow signal of the
deuterated NR2 probe is easily saturated by EPR irradiation,
which results in high PEDRI signal enhancement and allows
for shorter acquisition time. PEDRI applications for pH and
redox mapping of TME are discussed in a separate article of
this Forum (61).

FIG. 6. In vivo pH and redox assessment of TME in mouse model of breast cancer using dual-function NR1 probe.
(a) EPR insert: L-band EPR spectrum of the NR1 probe measured after i.t. injection (10 lL, 10 mM) in mammary tumor
tissue of anesthetized female FVB/N mice. The hyperfine splitting, aN, was found to be equal to 14.72 G, which corresponds
to the value of pHe = 6.52 assuming tumor tissue temperature 34C and pKa = 6.65. NR1 reduction rate is assessed by the
following: the decay of central-field spectral component. The exemplified kinetics measured in mammary tumor (-) and
mammary glands (B) demonstrates a higher reducing capacity of the tumor tissue versus normal mammary gland. The
analysis of the initial part of the kinetics yields the rates of the EPR signal reduction, kred, in extracellular media of the
tissues being equal to 2.5 · 10-3 s-1 in tumor versus 0.5 · 10-3 s-1 in normal gland. (b) Extracellular tissue pH (filled bars)
and the reduction rate (empty bars) values of NR1 nitroxide in normal mammary glands and mammary tumors of female
FVB/N mice measured by in vivo EPR. Error bars denote SE. Adapted from Ref. (10) with permission.
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FIG. 8. Redox mapping of tumor. Two-dimensional
spatial mapping of pseudofirst-order rate constants (left
panels) and frequency plot (right panels) of the nitroxide
reduction rate constants in the TME of untreated and BSOtreated mice are shown. Reproduced from Ref. (70) with
permission. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.
com/ars

FIG. 7. Mapping of extracellular tumor pH. (a) Coregistered EPR pH map and MRI of right hind leg of C3H mouse
bearing squamous cell carcinoma. A 4D (1 · spectral, 3 · spatial) 750 MHz continuous waves EPRI of low-field and highfield EPR peaks were performed using the following parameters: scan time, 0.3 s; modulation amplitude, 1.5 G; Gmax, 16
G/cm; FOV, 5.09 cm; projections, 576; and total acquisition
time, &6 min. EPR pH map was superimposed with six Varian
7T MRI image. (b) pH distributions from 3D volume measurement of right hind leg from control and tumor-bearing mice.
Adapted from Goodwin et al. (38) with permission. EPRI, EPR
imaging. To see this illustration in color, the reader is referred to
the web version of this article at www.liebertpub.com/ars
Figures 7 and 8 illustrate the applications of EPRI for pH
(38) and redox (70) mapping of the TME in living mice using
nitroxide probes. The three-dimensional EPR map of extracellular pH in TME of squamous cell carcinoma in right hind
leg of C3H mouse was measured after i.v. injection of cellimpermeable NR1 probe (Fig. 7a). Figure 7b shows a significantly more heterogeneous and acidic distribution of pHe
values in TME compared to normal tissue.
Figure 8 demonstrates the EPRI of TME reducing capacity
measured in RIF-1 tumor-bearing mice using cell-permeable
3-carbamoyl-proxyl nitroxide probe (70). An observation of
significant decrease in the rates of the NR signal decay for
the mice treated with glutathione biosynthesis inhibitor, Lbuthionine-S,R-sulfoximine, supports an important role of
GSH as an intracellular redox buffer.
In vivo EPR assessment of intracellular GSH

A ubiquitous thiol-containing tripeptide, GSH, presents
in virtually all mammalian tissues and plays a central role

in cell biology. The intracellular GSH concentrations in
mammalian cells are in the range between 1 and 10 mM and
are close to half of the total thiols/disulfides in the cells. The
redox couple of reduced GSH form and its oxidized disulfide form, GSSG, is a major component of intracellular
redox buffer (92, 95). A metabolic reprogramming in proliferating cancer cells results in enhanced NADPH formation via the pentose phosphate pathway interconnected with
glycolysis followed by facilitation of reduced GSH synthesis. High concentrations of GSH and low negative GSH
redox potentials have been found in cancer cells of various tumor types (10, 33, 48, 103, 105). Furthermore, it has
been demonstrated that tumor redox status can be modified
by tissue glutathione level, in vivo (70). An increased level
of GSH has been found in whole blood samples from patients with nonsmall-cell lung cancer (35) apparently reflecting high GSH concentration and low redox potential
characteristic for proliferating malignant cells of distant
malignant tissue.
The EPR approach allowing for assessment of glutathione
redox status in vivo using GSH-sensitive probes might provide a useful indicator of cancer progression and aggressiveness. Currently, EPR spectroscopy, in combination with
the disulfide biradicals of the imidazolidine type (59) (see
Fig. 2 for the RSSR structure) and its isotopically substituted
analogs (93), represents the only method that allows for
noninvasive quantitative [GSH] measurements in living
subjects in preclinical applications (10, 93). The RSSR probe
represents a paramagnetic analog of disulfide Ellman’s reagent (24, 25), which on the reaction of thiol/disulfide exchange with GSH splits its disulfide bond resulting in
formation of two monoradicals and cancelation of intramolecular spin-exchange between the monoradical fragments. Figure 9a illustrates the effect of reaction of the RSSR

EPR PROFILING OF TUMOR MICROENVIRONMENT
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FIG. 9. EPR assessment of intracellular glutathione. (a) The X-band EPR spectra of 100 lM RSSR measured at various time
points after incubation with 2.5 mM GSH in 0.1 M Na-phosphate buffer, pH 7.2, and 1 mM DTPA at 34C. The kinetics analysis
provides the observed rate constant value of the reaction between GSH and RSSR, kobs(pH 7.2, 34C) = (2.8 – 0.2) M-1 s-1. (b)
Kinetics of the monoradical spectral peak intensity change measured by L-band EPR in mammary tumor (C) and normal mammary
gland (B) of FVB/N mice immediately after i.t. injection of RSSR probe. The solid lines are the fits of the initial part of the kinetics
by the monoexponent supposing kobs (pH 7.2, 34C) = 2.8 M-1s-1 and yielding [GSH] = 10.7 and 3.3 mM for the tumor and normal
mammary gland, correspondingly. (c) Intracellular [GSH] measured using R2SSR2 probe in vivo in normal mammary glands and
mammary tumors of female FVB/N mice. Adapted from Ref. (10) with permission from John Wiley & Sons, Inc.

probe with glutathione on the EPR spectra resulting in disappearance of the ‘‘biradical’’ spectral components and a
corresponding increase of the intensity of the monoradical
components. The rate of the increase of the amplitude of the
monoradical component is proportional to the GSH concentration and is a convenient GSH-sensitive EPR spectral parameter. The observed rate constant of the reaction between
GSH and RSSR, kobs = 2.8 – 0.2 M-1s-1 (T = 34C, pH 7.2)
(10). This corresponds to the time constants of exponential
kinetics in the range from 0.6 to 6 min for the physiologically
relevant intracellular GSH concentration from 1 to 10 mM
providing an experimentally convenient time window for the
EPR detection. Note that the RSSR disulfide biradical being a
small lipophilic molecule easily crosses cellular membranes
where it reacts with intracellular GSH providing a reliable
approach for determination of GSH, in vivo (10, 93). This
EPR approach relies on a major contribution of the intracellular glutathione in the pool of the thiols easily accessible
for the reaction with the disulfide biradicals. Figure 9b exemplifies the kinetics of the monoradical spectral peak intensity change measured in mammary tumor (C) and normal
mammary gland (B) using L-band EPR. The solid lines are
the fits of the initial part of the kinetics by the monoexponent
yielding [GSH] = 10.7 and 3.3 mM for the tumor and normal
mammary gland, correspondingly.
Recently, new disulfide paramagnetic reagents, including
disulfide biradicals of pyrrolidine type (73), trityl-nitroxide
and trityl-trityl disulfide biradicals (78), were synthesized.
Trityl disulfides are cell impermeable (78) and do not allow
assessment of intracellular GSH. The use of pyrrolidine
disulfides for EPR assessment of thiols was demonstrated
in vitro (22, 73) and then in vivo for mapping thiol redox
status in tumor-bearing mice (31). Further comparative
studies of the rates of the penetration of the pyrrolidine disulfide nitroxides into the cells, their reaction with GSH, and
reduction by intracellular reductants are required to determine the capacity of these probes for quantitative in vivo EPR
measurement of intracellular glutathione concentrations.

In vivo concurrent EPR measurements
of tissue pO2, pHe, and Pi

Concurrent in vivo EPR measurements of the multiple
TME parameters using a single paramagnetic probe allow
for their correlation analysis independent of probe distribution, time of probe delivery, and spectrum acquisition,
therefore providing unique insight into the relationships
between these parameters in solid tumors (45). Recently, we
designed a trityl paramagnetic probe, HOPE, with unique
spectral properties (8, 20) that allowed for simultaneous
in vivo monitoring of tissue pH, pO2, and [Pi] in extracellular microenvironment in various animal models of cancer
(9, 20). Note that 31P NMR of endogenous phosphate predominantly measures intracellular phosphate while EPR
detects the HOPE probe in interstitial extracellular space:
bulky hydrophilic HOPE probe does not cross cellular
membrane and its EPR signal from the blood is not observed
due to probe complexation with plasma albumin (96).
Figure 10 illustrates functional sensitivities of the spectral
parameters of the HOPE probe.
Figure 11 illustrates multifunctional measurements performed in FVB/N wild-type mammary glands and in the
TME of MMTV-PyMT transgenic mice, which spontaneously develop breast cancer and emulate human tumor
staging (74). The comparison of the mean values of pO2 in
tumors and in normal tissues (50 – 3 mmHg vs. 58 – 3 mmHg,
correspondingly) and pHe (6.99 – 0.03 in TME vs. 7.1 – 0.03
in normal tissue) supports an appearance of hypoxic and
acidic regions in the tumor. The most significant several-fold
differences were observed for interstitial [Pi] (1.8 – 0.2 mM
in TME vs. 0.84 – 0.07 mM in normal tissue), indicating a
potential role of interstitial Pi as TME marker of tumor
progression. Figure 11e–h shows the correlation between the
individual values of the TME parameters measured with
the HOPE probe. The observed positive correlation between
pO2 and pHe in normal tissue versus the absence of correlation between these parameters in tumors supports tumor

1372

KHRAMTSOV

FIG. 10. Multifunctional assessment of chemical microenvironment using HOPE probe. (a) The scheme of pHdependent equilibrium between two ionization states of the probe. (b) L-band EPR spectrum of HOPE. (c) The EPR
linewidth of the HOPE is a pO2 marker (accuracy, &1 mmHg; pO2 range, 1–100 mmHg). (d) The fraction of HOPE3- form
is a pH marker in the range from 6 to 8.0 (accuracy, –0.05). (e) Dependence of proton exchange rate (expressed in mG) of
the HOPE with inorganic phosphate on Pi concentration extracted by spectra simulation (accuracy, –0.1 mM, range, 0.1–
20 mM) (8, 20). Reproduced from ref. (9) with permission from Nature Publishing Group. To see this illustration in color,
the reader is referred to the web version of this article at www.liebertpub.com/ars
reliance on glycolytic metabolism independent of oxygen
availability—the latter exemplifies in vivo manifestation of
Warburg effect. Figure 11g and h shows negative correlation
between pO2 and [Pi] both in normal tissue and TME supporting association of increase in [Pi] with changes in bioenergetic status on insufficient oxygen delivery.

The EPR profiling of TME of nonmetastatic PC14 and
metastatic PC14HM tumor xenografts using HOPE probe
showed that pO2 and pHe values do not significantly differ for
these two xenografts (9). On the contrary, extracellular inorganic phosphate concentrations allowed for discriminating
between nonmetastatic and metastatic tumors—the measured

FIG. 11. (a) Setup for in vivo L-band EPR measurements of the tissue microenvironment parameters in living mice.
Photograph shows the anesthetized mouse between the magnets of the EPR spectrometer with the insert on the right
showing placement and positioning of the loop resonator on top of the measured tissue. The values of pO2 (b), pHe (c), and
[Pi] (d) measured in normal mammary glands of FVB/N wild-type mice (MG, n = 23) and in the TME of breast cancer in
MMTV-PyMT transgenic mice (T, n = 18). Error bars are SD.*p = 0.065, **p = 0.006, ***p = 6 · 10-6. (e–h) Correlation
between interstitial pO2, pHe, and Pi values measured in MG and in the TME. To extend the range of oxygen variations,
anoxic conditions in interstitial space were established by i.t. injection of oxygen-consuming enzymatic system of glucose/
glucose oxidase (red symbols). Blue lines represent linear fit for the total data sets. (e) A positive correlation between pO2
and pHe in normal tissue (r = 0.5, p = 0.014 for black symbols; r = 0.64, p = 1.8 · 10-4 for total data set) versus (f) no
significant correlation between pO2 and pHe in TME (r = 0.01, p = 0.97 for black symbols; r = 0.23, p = 0.3 for total data set)
was found. (g) A negative correlation between pO2 and Pi both in normal tissue (r = -0.51, p = 0.013 for black symbols;
r = -0.7, p = 2.3 · 10-5 for total data set) and (h) in TME (b, bottom: r = -0.4, p = 0.079 for black symbols; r = -0.62,
p = 0.001 for total data set) was found. Adapted from Ref. (9) with permission. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
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FIG. 12. Intratumor GM-CSF injection slows tumor
growth and normalizes TME parameters. (a) PyMT+
FVB female mice with palpable tumors were treated with
PBS or 100 ng GM-CSF by intratumor injection thrice per
week. Points, mean tumor size from 8 (GM-CSF) and 10
(PBS) mice; bars, SE. Adapted from Ref. (34) with permission. (b–d) Normalization of TME of GM-CSF-treated
tumors as measured by in vivo EPR (measurements started 1
week after treatment initiation). The values of pH (b) and
reducing capacity of extracellular TME (c) were measured
using NR1 probe, and intracellular GSH values were measured using RSSR probe (d). Error bars denote SE. Adapted
from Ref. (10) with permission. GM-CSF, granulocyte
macrophage colony-stimulating factor; PBS, phosphatebuffered saline. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub
.com/ars
levels of [Pi] were significantly higher in the metastatic
PC14HM xenografts (9). The associate of high interstitial Pi
concentrations with alterations in tumor metabolism (98,
102), Pi contribution in buffer-facilitated proton transport
(39), and a high demand in phosphorus supply for the rapid
growth according to the ‘‘growth rate hypothesis’’ (26) may
underline the potential contribution in tumor progression and
aggressiveness [see Ref. (9) for detailed discussion]. Further
studies are required to evaluate physiological significance of
the observed high TME phosphate concentrations and the
amplification in highly metastatic tumors, and whether it may
provide additional opportunities for TME-targeted therapy.
Janus-faced TME and EPR profiling of normalization
during anticancer treatment

The increased rates of ROS generation (5, 75, 80, 87) and
lipid peroxidation (32, 72) have been measured in many
cancers. We hypothesized (55) that specific TME parameters
deviate from the corresponding counterparts in normal tissues facilitating extracellular ROS production and exposing
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cancer and nontransformed cells to a highly oxidizing environment. The cancer cells are well equipped with overexpressed antioxidant defense to survive in oxidative TME.
On the other side, an exposure of the normal cells to a highly
oxidizing environment may result in unavoidable and fatal
toxicity. This ‘‘Janus-faced’’ character of the TME facilitates
cancer growth at the expense of normal cells. Normalizing
parameters of the tissue microenvironment may decrease
selection pressure for malignant phenotype. Therefore, EPR
monitoring of TME parameters during anticancer treatment
may provide a tool for optimization of therapy efficiency and
contribute to the development of TME-targeted therapeutic
approaches.
Figure 12 illustrates an example of in vivo EPR profiling of
TME using functional probes, NR1 and RSSR, during the
treatment with anticancer drug (10). It has been reported a
significant decrease in tumor growth (Fig. 12a), angiogenesis,
metastases, and pO2 level on treatment with granulocyte
macrophage colony-stimulating factor (GM-CSF) in a PyMT
model of breast cancer (34). Figure 12b–d shows EPRmeasured TME parameters of PyMT mice bearing breast
cancer tumors not treated and treated with GM-CSF. Note
significant normalization of TME parameters on treatment
with GM-CSF, namely, an increase of pHe, decrease of tissue
reducing capacity, and GSH concentration.
Conclusions

The recent progress in EPR instrumentation designed to be
used in humans (100) and the development of biocompatible
paramagnetic probes with spectral sensitivity to the parameters of local chemical microenvironment eventually will
make possible the translation of EPR techniques for multifunctional profiling of TME into clinical settings. These
techniques will allow improving prediction power of early
diagnostics for malignant transition and for future rational
design of TME-targeted anticancer therapeutics.
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